Search PubMed⌕ Search

PubMed · 2750732

A method for combining matched and unmatched binary data. Application to randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy.

Abstract

A method for combining matched and unmatched data is described and was applied to the results of randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy. A pooled estimate from the matched and unmatched studies was obtained by adaptation of the Mantel-Haenszel method, where the strata were unmatched studies and matched pairs within studies. A test of significance was based on the Mantel-Haenszel chi-square statistic, the latter also being used to calculate test-based confidence intervals. A test of homogeneity was performed by combining Mantel-Haenszel chi-square statistics from the matched and unmatched studies. By these methods, the combined estimate of the risk of deterioration of visual acuity for those receiving photocoagulation (relative to a risk of unity for those not receiving photocoagulation) was 0.37 (95 per cent confidence interval 0.29-0.46). The chi-square statistic (1 df) for an effect of treatment was 87.75 (p less than 0.0001). The chi-square statistic for homogeneity of relative risk among studies was 11.20 (4 df, p less than 0.05). However, this result was influenced disproportionately by one small matched study.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S W Duffy, T E Rohan, D G Altman. 1989. A method for combining matched and unmatched binary data. Application to randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy.. https://doi.org/10.1093/oxfordjournals.aje.a115343

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Proteome analysis of human vitreous proteins.

PURPOSE: Various protein contents such as enzymes, growth factors, and structural components are responsible for biological activities in organs. We have created a map of vitreous proteins and developed a proteome analysis of human vitreous samples to understand the underlying molecular mechanism and to provide clues to new therapeutic approaches in eyes with proliferative diabetic retinopathy (PDR). METHODS: Vitreous and serum samples were obtained from subjects with idiopathic macular hole (MH, 26 cases) and PDR (33 cases). The expressed proteins in the samples were separated by two-dimensional (2-D) polyacrylamide gel electrophoresis. Protein spots were visualized by silver staining, and their expression patterns were analyzed. Some protein spots of concern were excised from the 2-D gels, digested in situ with trypsin, and analyzed by mass spectrometry. RESULTS: More than 400 spots were detected on 2-D gels of MH cases, of which 78 spots were successfully analyzed. The spots corresponded to peptide fragments of 18 proteins, including pigment epithelium-derived factor, prostaglandin-D2 synthase, and interphotoreceptor retinoid-binding protein. These were not identified in the corresponding serum samples. These proteins were also expressed in PDR samples, with no distinct tendency to increase or decrease compared with the MH samples. More than 600 spots were detected on 2-D gels of PDR cases, of which 141 spots were successfully analyzed. The spots corresponded to peptide fragments of 38 proteins. Enolase and catalase were identified among four detected spots. Neither was found in MH vitreous or in PDR serum samples. CONCLUSION: A map of protein expression was made in human vitreous from eyes with MH and PDR. In the PDR eyes, the increased protein expression observed was due to barrier dysfunction and/or production in the eye. Proteome analysis was useful in systematic screening of various protein expression in human vitreous samples.

Diabetic Retinopathy↗